CAR T therapy turns patient’s T-cells into cancer killers
FDA-approved treatment so new that many oncologists are unfamiliar with it
Bradford Neveu, 31, is currently undergoing CAR T-cell therapy at Methodist University Hospital. (Patrick Lantrip/Daily Memphian)
Topics
cancer CAR T-cell therapy Dr. Salil Goorha Dr. Yasser Khaled Methodist Le Bonheur Healthcare
Michelle Corbet
Michelle Corbet covers business for The Daily Memphian. Prior to, she was a reporter at the Memphis Business Journal. A native Memphian and University of Memphis graduate, Michelle covered business in Conway, Arkansas after college. Michelle got her start covering business as an intern at The Commercial Appeal.